United States · 
Who invested in Nanoscope Therapeutics?
Nanoscope Therapeutics's investors include National Institutes of Health.
United States · Funded startup
Who invested in Nanoscope Therapeutics
Funding summaryUpdated 26 Oct 2026
$1.5Mraised across 1 round since 2021, from 1 source
- Latest round
- Grant, $1.5MSept 2021
- Investors
- 1
The rounds
- Sept 2021
Founders and team
From Nanoscope Therapeutics's own website and the SEC filings it signed: 1 founder, 10 on the team.
Samarendra MohantyPresident, Chief Scientific Officer & Co-FounderNamed on its 2020 Form D
- Sulagna BhattacharyaChief Executive Officer
- Michael MarquezChief Financial Officer
- Paul HallenChief Operating Officer
- Samuel BaroneChief Medical Officer
- Gina Guillem JonesDirector
- Sunil GuptaDirector
- Ademola DaramolaTeam
- Jared StephensTeam
- Jean ChangTeam
- Ramesh ArjunjiTeam
On the board, as filediAlvaro Guillem
AdvisersThomas Ciulla
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Nanoscope Therapeutics
How much has Nanoscope Therapeutics raised?
Nanoscope Therapeutics has raised $1.5M across 1 round since 2021.
When did Nanoscope Therapeutics last raise?
Nanoscope Therapeutics's most recent round was a Grant of $1.5M in Sept 2021.
What was Nanoscope Therapeutics's biggest round?
Its most recent round, $1.5M in Sept 2021, is also its largest on record.
Who backed Nanoscope Therapeutics first?
Nanoscope Therapeutics's first round on record, in Sept 2021, was backed by National Institutes of Health.
What stage is Nanoscope Therapeutics at?
Nanoscope Therapeutics's latest named round is a Grant, in Sept 2021.
Where is Nanoscope Therapeutics based?
Nanoscope Therapeutics is based in the United States.
Companies like Nanoscope Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.